TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3086849

Group type: EXPERIMENTAL
Intervention: Patch A
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Patch B
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Patch C
Number of subjects: 30

Group type: COMPARATOR
Intervention: Comparison between patches A and B
Number of subjects: 30
Study: 30961367

Group type: EXPERIMENTAL
Intervention: New cotton-enhanced diaper
Number of subjects: 131

Group type: COMPARATOR
Intervention: Existing natural diaper
Number of subjects: 131
Study: 29921291

Group type: EXPERIMENTAL
Intervention: Endorectal Balloon (ERB)
Number of subjects: 10

Group type: COMPARATOR
Intervention: No Endorectal Balloon (ERB)
Number of subjects: 10
Study: 27102981

Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol 800μg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Buccal misoprostol 800μg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Oral misoprostol 800μg
Number of subjects: 18

Group type: COMPARATOR
Intervention: All routes of administration
Number of subjects: 18
Study: 25069975

Group type: EXPERIMENTAL
Intervention: mRDTs introduced in drug shops
Number of subjects: 0
Study: 22504283

Group type: EXPERIMENTAL
Intervention: Chef Initiative schools (healthier school lunches prepared by a professional chef)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control schools (standard school lunches)
Number of subjects: 2
Study: 20429831

Group type: EXPERIMENTAL
Intervention: EC-ASA 81 mg once daily alone
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: EC-ASA 81 mg once daily with acetaminophen 1 g four times daily
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: EC-ASA 81 mg once daily with NAPSO 220 mg three times daily
Number of subjects: 47
Study: 18467930

Group type: EXPERIMENTAL
Intervention: Rhythmic auditory stimulation at normal tempo
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Rhythmic auditory stimulation at fast tempo
Number of subjects: 17

Group type: COMPARATOR
Intervention: Normal walking without rhythm
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Walking as fast as safely possible without auditory rhythm
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Rhythmic auditory stimulation set 5% higher than fast walk
Number of subjects: 17
Study: 15939585

Group type: EXPERIMENTAL
Intervention: Third-generation non-steroidal aromatase inhibitors (NS-AIs) anastrozole and letrozole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Steroidal aromatase inhibitor (S-AI) exemestane
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Megestrol acetate
Number of subjects: 0
Study: 12442882

Group type: EXPERIMENTAL
Intervention: Donepezil 5 mg/day for the first 28 days and 10 mg/day thereafter (n = 102)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Donepezil (n = 102)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Placebo (n = 105)
Number of subjects: 207
Study: 10442786

Group type: COMPARATOR
Intervention: Various treatments in psychiatry
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proven treatments applied by psychiatrists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Health budget segmentation
Number of subjects: 0
Study: 8734751

Group type: EXPERIMENTAL
Intervention: Sintered platinum leads
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Activated pyrolytic carbon leads
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Vitreous carbon leads
Number of subjects: 99

Group type: COMPARATOR
Intervention: All lead types
Number of subjects: 99
Study: 1632690

Group type: EXPERIMENTAL
Intervention: Preoperative radiation therapy and surgery
Number of subjects: 148

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Preoperative radiation therapy and surgery (subset of 56 patients with locally advanced lesions)
Number of subjects: 148
Study: 6371695

Group type: EXPERIMENTAL
Intervention: Educational intervention involving a standardized interview and a printed information sheet for reinforcement 2 months later.
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (details not specified).
Number of subjects: 108
Study: 30914312

Group type: EXPERIMENTAL
Intervention: 19-G EBUS needle
Number of subjects: 107

Group type: COMPARATOR
Intervention: 22-G EBUS needle
Number of subjects: 107
Study: 28554173

Group type: EXPERIMENTAL
Intervention: Everolimus 10 mg/day
Number of subjects: 302

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 302
Study: 27837934

Group type: EXPERIMENTAL
Intervention: Selumetinib 75 mg
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Selumetinib 150 mg (predicted)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54

Group type: COMPARATOR
Intervention: Moxifloxacin (positive control)
Number of subjects: 54
Study: 24840317

Group type: EXPERIMENTAL
Intervention: INSULIN‐PH20
Number of subjects: 46

Group type: COMPARATOR
Intervention: Insulin lispro
Number of subjects: 46
Study: 22506468

Group type: EXPERIMENTAL
Intervention: Pedicled sternocleidomastoid muscle flap
Number of subjects: 73

Group type: COMPARATOR
Intervention: Direct suture (control)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Comparison between flap and control groups
Number of subjects: 73
Study: 20384591

Group type: EXPERIMENTAL
Intervention: MSICS
Number of subjects: 224

Group type: COMPARATOR
Intervention: Phacoemulsification
Number of subjects: 224
Study: 18320064

Group type: COMPARATOR
Intervention: CPG-DDS alone
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: CPG-DDS + artesunate 1 mg/kg
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: CPG-DDS + artesunate 2 mg/kg
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: CPG-DDS + artesunate 4 mg/kg
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Treatment emergent adverse events
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Serious adverse events
Number of subjects: 223
Study: 15797592

Group type: EXPERIMENTAL
Intervention: Base method debonding
Number of subjects: 50

Group type: COMPARATOR
Intervention: Wings method debonding
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 50
Study: 12455076

Group type: EXPERIMENTAL
Intervention: 40 mm long Scimed Cobra balloon followed by focal stenting
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: 60 mm long Scimed Cobra balloon followed by focal stenting
Number of subjects: 41
Study: 10874989

Group type: EXPERIMENTAL
Intervention: Cord blood IL-6 levels in infants of mothers considered to be noninfected
Number of subjects: 17

Group type: COMPARATOR
Intervention: Maternal blood IL-6 levels
Number of subjects: 17

Group type: COMPARATOR
Intervention: Peripheral infant blood IL-6 levels
Number of subjects: 17

Group type: COMPARATOR
Intervention: Clinical symptoms of infants
Number of subjects: 17

Group type: COMPARATOR
Intervention: Maternal prepartum treatment with antibiotics and/or steroids
Number of subjects: 17

Group type: COMPARATOR
Intervention: Low infant blood IL-6 level
Number of subjects: 17
Study: 8609325

Group type: EXPERIMENTAL
Intervention: Ibutilide (0.005 to 0.025 mg/kg body weight)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Ibutilide (nonconverters)
Number of subjects: 35
Study: 1930840

Group type: EXPERIMENTAL
Intervention: Pumice prophylaxis with a rubber cup and slow‐speed handpiece
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional fluoridated dentifrice (Colgate)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Triclosan/copolymer/NaF dentifrice (Colgate)
Number of subjects: 45
Study: 7295460

Group type: EXPERIMENTAL
Intervention: Phenobarbitone 80 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Phenobarbitone 140 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Phenobarbitone 240 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Phenobarbitone (all doses)
Number of subjects: 24
Study: 31054246

Group type: EXPERIMENTAL
Intervention: Palmitoylethanolamide (PEA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 0
Study: 29026123

Group type: EXPERIMENTAL
Intervention: Happy mood induced by listening to music excerpts for about 10 minutes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sad mood induced by listening to music excerpts for about 10 minutes
Number of subjects: 0
Study: 27734108

Group type: EXPERIMENTAL
Intervention: 3M™ IV Advanced dressing
Number of subjects: 628

Group type: COMPARATOR
Intervention: Hospital's classical transparent dressing
Number of subjects: 628
Study: 24842062

Group type: EXPERIMENTAL
Intervention: Initial bone preparation followed by a 2-week delay before implant placement
Number of subjects: 12

Group type: COMPARATOR
Intervention: Conventional protocol
Number of subjects: 12
Study: 22527786

Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg intravenously
Number of subjects: 372

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 372
Study: 21400763

Group type: EXPERIMENTAL
Intervention: Surgical treatment for cruciate ligament injury
Number of subjects: 16
Study: 17608975

Group type: EXPERIMENTAL
Intervention: Videolaryngoscope
Number of subjects: 80

Group type: COMPARATOR
Intervention: Direct vision (Control)
Number of subjects: 80
Study: 16306834

Group type: EXPERIMENTAL
Intervention: Short-segment (SS) pedicle fixation
Number of subjects: 18

Group type: COMPARATOR
Intervention: Long-segment (LS) instrumentation
Number of subjects: 18
Study: 12487321

Group type: EXPERIMENTAL
Intervention: Camphor-Crataegus berry combination (CCC) - 5 drops
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Camphor-Crataegus berry combination (CCC) - 20 drops
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Camphor-Crataegus berry combination (CCC) - 80 drops
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (20 drops of a 60% alcoholic solution)
Number of subjects: 48
Study: 9583346

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Aerobic plus strength training combined
Number of subjects: 77

Group type: COMPARATOR
Intervention: No exercise (control group)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Regular exercise in the 4 months preceding follow-up
Number of subjects: 77
Study: 8130051

Group type: EXPERIMENTAL
Intervention: Isoflurane-nitrous oxide (n = 10) at concentrations of 1.5-1.95 MAC
Number of subjects: 20

Group type: COMPARATOR
Intervention: Halothane-nitrous oxide (n = 10) at concentrations of 1.5-1.95 MAC
Number of subjects: 20

Group type: COMPARATOR
Intervention: Comparison of isoflurane-nitrous oxide and halothane-nitrous oxide
Number of subjects: 20

Group type: COMPARATOR
Intervention: Isoflurane-nitrous oxide and halothane-nitrous oxide at equiMAC concentrations
Number of subjects: 20
Study: 2658793

Group type: EXPERIMENTAL
Intervention: Double-beta-lactam group (netilmicin plus piperacillin or azlocillin)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Single-beta-lactam group (ceftazidime plus piperacillin or azlocillin)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Single-beta-lactam combination
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Double-beta-lactam group
Number of subjects: 174
Study: 31895303

Group type: EXPERIMENTAL
Intervention: Kangaroo mother care (n = 30), provided twice a day until discharge
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (n = 30), routine application only
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Kangaroo mother care (n = 30)
Number of subjects: 60
Study: 29050753

Group type: EXPERIMENTAL
Intervention: Spray Cryotherapy (SCT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (without SCT)
Number of subjects: 40
Study: 26086183

Group type: EXPERIMENTAL
Intervention: NBP 200 mg three times daily
Number of subjects: 281

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 281
Study: 26247144

Group type: EXPERIMENTAL
Intervention: Mechanical-CPR
Number of subjects: 2589

Group type: COMPARATOR
Intervention: Manual-CPR
Number of subjects: 2589
Study: 22772956

Group type: EXPERIMENTAL
Intervention: Multi-level intervention to prevent childhood obesity
Number of subjects: 221
Study: 20361860

Group type: EXPERIMENTAL
Intervention: High-fidelity patient simulation (including face-to-face instruction)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Online, narrated PowerPoint presentation
Number of subjects: 20
Study: 18586530

Group type: EXPERIMENTAL
Intervention: Cement pressurization technique with pegged glenoid component
Number of subjects: 81
Study: 16630205

Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 2
Study: 12818310

Group type: EXPERIMENTAL
Intervention: LDL/HDL ratio
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LDL levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TC/HDL ratio
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Changes in ratios
Number of subjects: 0
Study: 11251396

Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation (SCS)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 120
Study: 8860279

Group type: EXPERIMENTAL
Intervention: Tobacco use prevention intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined tobacco and dietary intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary modification intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dietary modification-only condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study: 1637215

Group type: EXPERIMENTAL
Intervention: Glucose-insulin-potassium infusion (500 mL of 30% glucose containing 300 units of insulin and 5 g of potassium chloride at a rate of 1.66 mL.kg‐1.h‐1 for 1 hour before cardiopulmonary bypass)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glucose-insulin-potassium infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6391736

Group type: EXPERIMENTAL
Intervention: Alum-precipitated five-grass extract (Allpyral)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Two-grass conjugated extract (Conjuvac)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Both groups (Allpyral and Conjuvac)
Number of subjects: 39
Study: 31570123

Group type: EXPERIMENTAL
Intervention: Online mindfulness course (4-week duration)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Usual education (control group)
Number of subjects: 52
Study: 30392525

Group type: EXPERIMENTAL
Intervention: Buffered Tumescent Local Anaesthesia (BT)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Standard Tumescent Local Anaesthesia (ST)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Both groups (BT and ST)
Number of subjects: 97
Study: 27233840

Group type: COMPARATOR
Intervention: Nicotine Replacement Therapy (NRT) - 21 mg daily maximum for 10 weeks
Number of subjects: 737

Group type: COMPARATOR
Intervention: Nicotine Replacement Therapy Plus (NRT+) - 35 mg daily maximum patches and gum/inhaler for up to 22 weeks
Number of subjects: 737

Group type: COMPARATOR
Intervention: Varenicline (VR) - 1 mg twice daily for up to 24 weeks
Number of subjects: 737
Study: 24590752

Group type: EXPERIMENTAL
Intervention: Prenatal lipid‐based nutrient supplements (LNS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Multiple micronutrient supplement
Number of subjects: 0
Study: 21785956

Group type: EXPERIMENTAL
Intervention: Multidisciplinary treatment program including massage therapy, ischemic pressure, aerobic exercise, and thermal therapy for 8 weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group continued medical treatment and participated in four educational sessions
Number of subjects: 34
Study: 20346133

Group type: EXPERIMENTAL
Intervention: Classification-based treatment
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual care according to Dutch LBP guidelines
Number of subjects: 150
Study: 17346248

Group type: EXPERIMENTAL
Intervention: Oxcarbazepine (OXCZ) 1200 mg daily for 17 days
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ) 800 mg daily for 17 days
Number of subjects: 10
Study: 16334861

Group type: EXPERIMENTAL
Intervention: Bilayered skin construct (BSC)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Healing by secondary intention
Number of subjects: 31
Study: 12516643

Group type: EXPERIMENTAL
Intervention: Brånemark implants
Number of subjects: 28

Group type: COMPARATOR
Intervention: ITI implants
Number of subjects: 28
Study: 9709422

Group type: EXPERIMENTAL
Intervention: Technique for obtaining rotational alignment during closed locked intramedullary nailing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional methods of judging alignment
Number of subjects: 0
Study: 8596132

Group type: EXPERIMENTAL
Intervention: FAM (5-fluorouracil, adriamycin, mitomycin C) regimen
Number of subjects: 26

Group type: COMPARATOR
Intervention: ELF (etoposide, leucovorin, 5-fluorouracil) regimen
Number of subjects: 26

Group type: COMPARATOR
Intervention: ELF regimen
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: FAM regimen
Number of subjects: 26
Study: 2295264

Group type: EXPERIMENTAL
Intervention: Thiabendazole
Number of subjects: 6

Group type: COMPARATOR
Intervention: Mebendazole
Number of subjects: 6
Study: 582924

Group type: EXPERIMENTAL
Intervention: vincamine-cromesilate (Vincaryl)
Number of subjects: 26

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 26
Study: 28651779

Group type: EXPERIMENTAL
Intervention: Below the artery (BA) technique
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Around the artery (AA) technique
Number of subjects: 240

Group type: COMPARATOR
Intervention: Perineural (PN) technique
Number of subjects: 240
Study: 28651929

Group type: EXPERIMENTAL
Intervention: Nivolumab 3 mg/kg every 2 weeks
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 361

Group type: COMPARATOR
Intervention: Investigator's choice (methotrexate, docetaxel, or cetuximab)
Number of subjects: 361

Group type: COMPARATOR
Intervention: Investigator's choice
Number of subjects: 361
Study: 26248851

Group type: EXPERIMENTAL
Intervention: Low dialysate sodium concentration
Number of subjects: 96

Group type: COMPARATOR
Intervention: Standard dialysate sodium concentration
Number of subjects: 96
Study: 24693626

Group type: EXPERIMENTAL
Intervention: Chewing gum containing 0.1% zinc lactate and 0.01% allyl isothiocyanate
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 15
Study: 21389120

Group type: EXPERIMENTAL
Intervention: MHD intravenously (250 mg infused over 30 min)
Number of subjects: 12

Group type: COMPARATOR
Intervention: OXC orally (one film-coated 300-mg tablet)
Number of subjects: 12
Study: 18513390

Group type: EXPERIMENTAL
Intervention: Brief self-management techniques
Number of subjects: 126

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 126
Study: 15767643

Group type: EXPERIMENTAL
Intervention: Enoxaparin 40 mg once a day
Number of subjects: 385

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 385
Study: 11920979

Group type: EXPERIMENTAL
Intervention: Modified treatment including mirror confrontation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 0
Study: 9865192

Group type: EXPERIMENTAL
Intervention: High-energy, pulsed CO2 laser
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combination CO2 and PDL laser treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: CO2 laser irradiation alone
Number of subjects: 20
Study: 7846138

Group type: EXPERIMENTAL
Intervention: Traction
Number of subjects: 3
Study: 2136969

Group type: EXPERIMENTAL
Intervention: Anaritide (human atrial natriuretic peptide 102‐126) administered as 1‐hour infusions at a rate of 0.03 to 0.3 micrograms/kg/min
Number of subjects: 35

Group type: COMPARATOR
Intervention: Anaritide (0.03 to 0.6 micrograms/kg/min)
Number of subjects: 35
Study: 402543

Group type: EXPERIMENTAL
Intervention: Actihaemyl (0.5 ml per kg body weight)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Fludilat (200 mg)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Trental (200 mg)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: None of the substances investigated
Number of subjects: 88
Study: 30980433

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Stress Management (CBSM)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Psychoeducation (PE)
Number of subjects: 94
Study: 27849400

Group type: COMPARATOR
Intervention: Q-switched neodymium:yttrium aluminum garnet (QSNd:YAG) laser at a fluence of 10 joule/cm2, 10 Hz and 2 mm spot size
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Erbium:yttrium aluminum garnet (Er:YAG) laser at 200-300 millijoule, 4 Hz and 2 mm spot size
Number of subjects: 60
Study: 25349179

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation for 6 months
Number of subjects: 691

Group type: COMPARATOR
Intervention: Household income level
Number of subjects: 691
Study: 24102928

Group type: EXPERIMENTAL
Intervention: Gabapentin enacarbil (GEn) 3,600 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gabapentin enacarbil (GEn) 1,200 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gabapentin enacarbil (GEn) 2,400 mg/day
Number of subjects: 0
Study: 21576533

Group type: EXPERIMENTAL
Intervention: 100 mcg/d selenium supplementation
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: 200 mcg/d selenium supplementation
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: 300 mcg/d selenium supplementation
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Selenium supplementation (all doses)
Number of subjects: 501

Group type: COMPARATOR
Intervention: Yeast-based placebo
Number of subjects: 501
Study: 19428401

Group type: EXPERIMENTAL
Intervention: Pergolide
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Pramipexole
Number of subjects: 19

Group type: COMPARATOR
Intervention: Healthy Controls (HC)
Number of subjects: 19
Study: 16460521

Group type: EXPERIMENTAL
Intervention: Self-explanation with instruction
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Self-explanation without instruction
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Direct instruction with self-explanation
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Direct instruction without self-explanation
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control (no self-explanation)
Number of subjects: 85